Skip to main content
European Commission logo print header

Role of descending hippocampal outputs in anxiety studied using a novel pharmaco-genetic efferent inhibition tool

Objectif

The brain structures and neural circuits regulating anxiety behavior are poorly understood. The hippocampus contribute to anxiety via its role in the behavioral inhibition system and descending outputs via the fornix to the septum and frontal cortex are thought to be critical to this modulating effect. However, it is not clear what the contributions of septal and frontal cortical outputs are to anxiety because, until now, no manipulations were available to selectively inhibit these pathways. Here we propose to develop a pharmacogenetic inhibition technology to selectively manipulate hippocampal efferents and determine the contribution of specific hippocampal outputs to anxiety behavior. The host laboratory has already developed a method for the inhibition of genetically defined cell populations in behaving mice. During the first part of the fellowship, I will develop a modified version of this technology based on axonally transported inhibitory GPCRs that allows for the pharmacological suppression of neurotransmitter release in genetically defined synapses. Later, I will use this technology to examine the behavioral effects of blocking selected hippocampal outputs, with a primary focus on hippocampus-frontal cortex projections. The expectation is that the development and validation of this technology will open up a novel approach to study brain function.

Appel à propositions

FP7-PEOPLE-2010-IEF
Voir d’autres projets de cet appel

Coordinateur

EUROPEAN MOLECULAR BIOLOGY LABORATORY
Contribution de l’UE
€ 181 084,00
Adresse
Meyerhofstrasse 1
69117 Heidelberg
Allemagne

Voir sur la carte

Région
Baden-Württemberg Karlsruhe Heidelberg, Stadtkreis
Type d’activité
Research Organisations
Contact administratif
Genevieve Reinke (Ms.)
Liens
Coût total
Aucune donnée